Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).
Hubbard JM, Mahoney MR, Loui WS, Roberts LR, Smyrk TC, Gatalica Z, Borad M, Kumar S, Alberts SR. Hubbard JM, et al. Among authors: roberts lr. Target Oncol. 2017 Apr;12(2):201-209. doi: 10.1007/s11523-016-0467-0. Target Oncol. 2017. PMID: 27943153 Free PMC article. Clinical Trial.
Emerging drugs for hepatocellular carcinoma.
Roberts LR, Gores GJ. Roberts LR, et al. Expert Opin Emerg Drugs. 2006 Sep;11(3):469-87. doi: 10.1517/14728214.11.3.469. Expert Opin Emerg Drugs. 2006. PMID: 16939386 Review.
Treatment options for hepatobiliary and pancreatic cancer.
Alberts SR, Gores GJ, Kim GP, Roberts LR, Kendrick ML, Rosen CB, Chari ST, Martenson JA. Alberts SR, et al. Among authors: roberts lr. Mayo Clin Proc. 2007 May;82(5):628-37. doi: 10.4065/82.5.628. Mayo Clin Proc. 2007. PMID: 17493429 Review.
Treatment options for hepatocellular carcinoma.
Sandhu DS, Tharayil VS, Lai JP, Roberts LR. Sandhu DS, et al. Among authors: roberts lr. Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):81-92. doi: 10.1586/17474124.2.1.81. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072372 Review.
Epidemiology and management of hepatocellular carcinoma.
Yang JD, Roberts LR. Yang JD, et al. Among authors: roberts lr. Infect Dis Clin North Am. 2010 Dec;24(4):899-919, viii. doi: 10.1016/j.idc.2010.07.004. Infect Dis Clin North Am. 2010. PMID: 20937457 Free PMC article. Review.
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.
Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts LR. Moreno-Luna LE, et al. Among authors: roberts lr. Cardiovasc Intervent Radiol. 2013 Jun;36(3):714-23. doi: 10.1007/s00270-012-0481-2. Epub 2012 Oct 24. Cardiovasc Intervent Radiol. 2013. PMID: 23093355 Free PMC article.
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.
Graham RP, Barr Fritcher EG, Pestova E, Schulz J, Sitailo LA, Vasmatzis G, Murphy SJ, McWilliams RR, Hart SN, Halling KC, Roberts LR, Gores GJ, Couch FJ, Zhang L, Borad MJ, Kipp BR. Graham RP, et al. Among authors: roberts lr. Hum Pathol. 2014 Aug;45(8):1630-8. doi: 10.1016/j.humpath.2014.03.014. Epub 2014 Apr 13. Hum Pathol. 2014. PMID: 24837095
520 results